Doitu Acne Microcrystalline Invisible Acne Patch
NDC Package 83093-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Doitu Acne Microcrystalline Invisible Acne Patch is before use, it is recommended to clean the acne area on the face first. Marketed by Guangdong Zhizhen Biological Medicine Co., Ltd., this product is identified by NDC 83093-101.

Identification & Billing

NDC Package Code
83093-101-01
Package Description
40 mg in 1 PATCH
Product Code
11-Digit Billing Format
83093010101

Clinical Specifications

Proprietary Name
Doitu Acne Microcrystalline Invisible Acne Patch
Dosage Form
-
Usage Information
Before use, it is recommended to clean the acne area on the face first. After the skin is dry, tear off an acne patch from the film, align it with the center of the acne, gently stick it on the acne, and gently press it with the finger pulp to make it stick. If you need to make up, please use the acne patch first and then apply makeup.

Regulatory & Marketing

Labeler Name
Guangdong Zhizhen Biological Medicine Co., Ltd.
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-25-2022
Listing Expiration
12-31-2023
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (83093-101). Click a package code to view its specific billing and regulatory data.

40 mg in 1 PATCH
40 mg in 1 PATCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83093-101-01 identifies a specific commercial package of 40 mg in 1 patch of Doitu Acne Microcrystalline Invisible Acne Patch, labeled by Guangdong Zhizhen Biological Medicine Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Guangdong Zhizhen Biological Medicine Co., Ltd. on November 25, 2022. The current certification is valid through December 31, 2023.

How is this Guangdong Zhizhen Biological Medicine Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83093010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83093-101-01
11-Digit CMS (5-4-2)
83093-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.